Influence of common drugs and related factors on stroke outcome

Current Opinion in Neurology

Volumn 10, Issue 1, 1997, Pages 52-57

  Goldstein, Larry B ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMITRIPTYLINE; AMPHETAMINE; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; APOMORPHINE; BROMOCRIPTINE; BUTYROPHENONE DERIVATIVE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DESIPRAMINE; DIAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; FLUOXETINE; HALOPERIDOL; IDAZOXAN; METHYLPHENIDATE; NEUROTRANSMITTER; PHENOBARBITAL; PHENOXYBENZAMINE; PHENTERMINE; PHENYLPROPANOLAMINE; PHENYTOIN; PRAZOSIN; PROPRANOLOL DERIVATIVE; SCOPOLAMINE; TRAZODONE; YOHIMBINE;

DRUG EFFECT; DRUG EFFICACY; HUMAN; MOTOR CORTEX; SENSORIMOTOR CORTEX; SHORT SURVEY; STROKE; TRAINING;

EID: 0030973882     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199702000-00011     Document Type: Short Survey

References (79)

1. Feeney DM, Gonzalez A, Law WA: Amphetamine, haloperidol, and experience interact to affect the rate of recovery after motor cortex injury. Science 1982, 217:855-857.
2. Hurwitz BE, Dietrich WD, McCabe PM, Watson BD, Ginsberg MD, Schneiderman N: Amphetamine-accelerated recovery from cortical barrel-field infarction: pharmacological treatment of stroke. In Cerebrovascular diseases. The sixteenth research (Princeton) conference. Edited by Ginsberg MD, Dietrich WD. New York: Raven Press; 1989:309-318.
3. Stroemer RP, Kent TA, Hulsebosch CE: Amphetamines permanently promote recovery following cortical infarction. Soc Neurosci Abstr 1994, 20:186.
4. Feeney DM, Sutton RL: Catecholamines and recovery of function after brain damage. In Pharmacological approaches to the treatment of brain and spinal cord injury. Edited by Stein DG, Sabel BA. New York: Plenum Publishing Corporation; 1988:121-142.
5. Prasad RM, Dose JM, Dhillon HS, Carbary T, Kraemer PJ: Amphetamine affects the behavioral outcome of lateral fluid percussion brain injury in the rat. Restor Neurol Neurosci 1995, 9:65-75.
6. Hovda DA, Feeney DM: Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res 1984, 298:358-361.
7. Meyer PM, Horel JA, Meyer DR: Effects of d-amphetamine upon placing responses in neodecorticate cats. J Comp Physiol Psych 1963, 56:402-404.
8. Sutton RL, Hovda DA, Feeney DM: Amphetamine accelerates recovery of locomotor function following bilateral frontal cortex ablation in cats. Behav Neurosci 1989, 103:837-841.
9. Goldstein LB: Amphetamine-facilitated functional recovery after stroke. In Cerebrovascular diseases. The sixteenth research (Princeton) conference. Edited by Ginsberg MD, Dietrich WD, New York: Raven Press, 1989:303-308.
10. 2-adrenergic receptor antagonist. Ann Neurol 1989, 26:157.
11. Feeney DM, Westerberg VS: Norepinephrine and brain damage: alpha noradrenergic pharmacology alters functional recovery after cortical trauma. Can J Psychol 1990, 44:233-252.
12. Sutton RL, Feeney DM: α-Noradrenergic agonists and antagonists affect recovery and maintenance of beam-walking ability after sensorimotor cortex ablation in the rat. Restor Neurol Neurosci 1992, 4:1-11.
13. Irish SL, Davis GW, Barth TM: A specific behavioral role for norepinephrine in the recovery of locomotor placing following cortical lesions in the rat. Soc Neurosci Abstr 1995, 21:170.
14. Hovda DA, Bailey B, Montoya S, Salo AA, Feeney DM: Phentermine accelerates recovery of function after motor cortex injury in rats and cats. Fed Am Soc Exp Biol 1983, 42:1157.
15. Chen MJ, Sutton RL, Feeney DM: Recovery of function after brain injury in rat and cat: beneficial effects of phenylpropanolamine. Soc Neurosci Abstr 1986, 12:881.
16. Feeney DM, Sutton RL: Pharmacotherapy for recovery of function after brain injury. CRC Crit Rev Neurobiol 1987, 3:135-197.
17. Kline AE, Chen MJ, Tso-Olivas DY, Feeney DM: Methylphenidate treatment following ablation-induced hemiplegia in rat: experience during drug action alters effects on recovery of function. Pharmacol Biochem Behav 1984, 48:773-779.
18. Goldstein LB, Davis JN: Clonidine impairs recovery of beam-walking in rats. Brain Res 1990, 508:305-309.
19. Stephens J, Goldberg G, Demopoulos JT: Clonidine reinstates deficits following recovery from sensorimotor cortex lesion In rats. Arch Phys Med Rehabil 1986, 67:666-667.
20. Hovda DA, Feeney DM, Salo AA, Boyeson MG: Phenoxybenzamine but not haloperidol reinstates all motor and sensory deficits in cats fully recovered from sensorimotor cortex ablations. Soc Neurosci Abstr 1983, 9:1002.
21. Hovda DA, Feeney DM: Haloperidol blocks amphetamine induced recovery of binocular depth perception after bilateral visual cortex ablation In the cat. Proc West Pharmacol Soc 1985, 28:209-211.
22. Hovda DA, Sutton RL, Feeney DM: Amphetamine-induced recovery of visual cliff performance after bilateral visual cortex ablation in cats: measurements of depth perception thresholds. Behav Neurosci 1989, 103:574-584.
23. Van Hasselt P: Effect of butyrophenones on motor function in rats after recovery from brain damage. Neuropharmacology 1973, 12:245-247.
24. 1-class dopamine receptor involvement in the behavioral recovery from prefrontal cortical Injury. Behav Brain Res 1996, 72:39-48.
25. Corwin JV, Kanter S, Watson RT, Heilman KM, Valenstein E, Hashimoto A: Apomorphlne has a therapeutic effect on neglect produced by unilateral dorsomedial prefrontal cortex lesions In rats. Exper Neurol 1986, 94:683-689.
26. Vargo JM, Richard-Smith M, Corwin JV: Spiroperidol reinstates asymmetries in neglect in rats recovered from left or right dorsomedial prefrontal cortex lesions. Behav Neurosci 1989, 103:1017-1027.
27. Boyeson MG, Harmon RL: Effects of trazodone and desipramine on motor recovery in brain-injured rats. Am J Phys Med Rehabil 1993, 72:286-293.
28. Boyeson MG, Harmon RL, Jones JL: Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury. Am J Phys Med Rehabil 1994, 73:76-83.
29. Brailowsky S, Knight RT, Blood K: γ-aminobutyric acid-induced potentiation of cortical hemiplegia. Brain Res 1986, 362:322-330.
30. Schallert T, Hernandez TD, Barth TM: Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res 1986, 379:104-111.
31. Hernandez TD, Kiefel J, Barth TM, Grant ML, Schauert T: Disruption and facilitation of recovery of behavioral function: implication of the γ-aminobutyric acid/benzodiazepine receptor complex. In Cerebrovascular diseases. The sixteenth research (Princeton) conference. Edited by Ginsberg MD, Dietrich WD. New York: Raven Press; 1989:327-334.
32. Moratalla R, Barth TM, Bowery NG: Benzodiazapine receptor autoradiography in corpus striatum of rat after frontal cortex lesion and chronic diazepam treatment. Neuropharmacology 1989, 28:893-900.
33. Schallert T, Jones TA, Weaver MS, Shapiro LE, Crippens D, Fulton R: Pharmacologic and anatomic considerations in recovery of function. Physic Med Rehab 1992, 6:375-393.
34. Brailowsky S, Knight RT, Efron R: Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res 1986, 376:71-77.
35. Chweh AY, Swinyard EA, Wolf HH: Involvement of a GABAergic mechanism in the pharmacologic action of phenytoin. Pharmacol Biochem Behav 1986, 24:1301-1304.
36. Hernandez TD, Holling LC: Disruption of behavioral recovery by the anti-convulsant phenobarbital. Brain Res 1994, 635:300-306.
37. Watson CW, Kennard MA: The effect of anticonvulsant drugs on recovery of function following cerebral cortical lesions. J Neurophysiol 1945, 8:221-231.
38. Ward AA Jr, Kennard MA: Effect of cholinergic drugs on recovery of function following lesions of the central nervous system in monkeys. Yale J Biol & Med 1942, 15:189-228.
39. Hayes RL, Lyeth BG, Dixon CE, Stonnington HH, Becker DP: Cholinergic antagonist reduces neurologic deficits following cerebral concussion in the rat. J Cereb Blood Flow Metab 1985, 5(suppl 1): S395-S396.
40. Lyeth BG, Ray M, Hamm RJ, Schnabel J, Saady JJ, Poklis A, Jenkins LW, Gudeman SK, Hayes RL: Postinjury scopolamine administration in experimental traumatic brain injury. Brain Res 1992, 569:281-286.
41. Saponjic RM, Hoane MR, Barbay S, Barth TM: Scopolamine facilitates recovery of function following unilateral electrolytic sensorimotor cortex lesions in the rat. Restor Neurol Neurosci 1995, 8:205-212.
42. De Ryck M, Duytschaever H, Janssen PAJ: Ionic channels, cholinergic mechanisms, and recovery of sensorimotor function after neocortical infarcts in rats. Stroke 1990, 21(suppl III):III-158-III-163.
43. Goldstein LB: Pharmacology of recovery after stroke. Stroke 1990, 21(suppl III):III-139-III-142.
44. Goldstein LB: Pharmacologic modulation of recovery after stroke: clinical data. J Neuro Rehab 1991, 5:129-140.
45. Goldstein LB: Drugs and stroke recovery. Neurology 1996, 46:1187-1188.
46. Schwartz RD, Huff RA, Yu X, Carter ML, Bishop M: Postischemic diazepam is neuroprotective in the gerbil hippocampus. Brain Res 1994, 647:153-160.
47. Johansen FF, Diemer NH: Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells. Acta Neurol Scand 1991, 84:1-6.
48. Schwartz RD, Yu X, Katzman MR, Hayden-Hixson DM, Perry JM: Diazepam, given postischemia, protects selectively vulnerable neurons In the rat hippocampus and striatum. J Neurosci 1995, 15:529-539.
49. Stemau LL, Lust WD, Ricci AJ, Ratcheson R: Role for γ-aminobutyric acid in selective vulnerability in gerbils. Stroke 1989, 20:281-287.
50. Smith AL, Hoff JT, Nielsen SL, Larson CP: Barbiturate protection in acute focal cerebral ischemia. Stroke 1974, 5:1-7.
51. Boxer PA, Cordon JJ, Mann ME, Rodolosi LC, Vartanian MG, Rock DM, Taylor CP, Marcoux FW: Comparison of phenytoin with noncompetitive N-methyl-D-aspartate anatagonists in a model of focal brain iscemia in the rat. Stroke 1990, 21(suppl III):III-47-III-51.
52. Lyden PD, Lonzo L: Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a γ-aminobutyric acid agonist. Stroke 1994, 25:189-196.
53. Lyden PD, Hedges B: Protective effect of synaptic inhibition during cerebral ischemia in rats and rabbits. Stroke 1992, 23:1463-1470.
54. Lyden P, Lonzo L, Nunez S: Combination chemotherapy extends the therapeutic window to 60 minutes after stroke. J Neurotrauma 1995, 12:223-230.
55. Feeney DM, Hovda DA: Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Res 1985, 342:352-356.
56. Goldstein LB, Davis JN: Post-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat. Restor Neurol Neurosci 1990, 1:311-314.
57. Kline AE, Flores TP, Tso-Olivas DY, Chen MJ, Feeney DM: Effects of methylphenidate on recovery from ablation-induced hemiplegia. Soc Neurosci Abstr 1988, 14:1152.
58. Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S: The poststroke hemiplegic patient. I. A method for evaluation of physical performance. Scand J Rehab Med 1975, 7:13-31.
59. Reding MJ, Solomon B, Borucki SJ: Effect of dextroamphetamine on motor recovery after stroke. Neurology 1995, 45(suppl 4):A222. A negative, small, clinical study testing the effect of d-amphetamine on recovery after stroke.
60. Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R: Amphetamine paired with physical therapy accelerates motor recovery after stroke - further evidence. Stroke 1995, 26:2254-2259. A small, clinical trial of the effects of amphetamine on motor recovery in patients undergoing post-stroke rehabilitation. Treated patients showed a significant benefit that was maintained up to 1 year after the treatment was completed.
61. Johnson ML, Roberts MD, Ross AR, Witten CM: Methylphenidate in stroke patients with depression. Am J Phys Med Rehabil 1992, 71:239-241.
62. Lazarus LW, Moberg PJ, Langsley PR, Ungam VR: Methylphenidate and nortriptyline in the treatment of poststroke depression: a retrospective comparison. Arch Phys Med Rehabil 1994, 75:403-406.
63. Lazarus LW, Winemiller DR, Lingam VR, Neyman I, Hartman C, Abassian M, Kartan U, Groves L, Fawcett J: Efficacy and side effects of methylphenidate for poststroke depression. J Clin Psychiatry 1992, 53:447-449.
64. Larsson M, Ervik M, Lundborg P, Sundh V, Svanborg A: Comparison between methylphenidate and placebo as adjuvant in care and rehabilitation of geriatric patients. Comp Gerontol 1988, 2:53-59.
65. Reding MJ, Orto LA, Winter SW, Fortuna IM, Di Ponte P, McDowell FH: Antidepressant therapy after stroke. A double-blind trial. Arch Neurol 1986, 43:763-765.
66. Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M, Freo U, Piron L, Battistin L: Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996, 27:1211-1214. Larger clinical trial in which post-stroke rehabilitation patients were randomized to receive fluoxetine, maprotiline or placebo. Greatest funcional improvements were seen in the fluoxetine-treated group and the smallest in maprotiline-treated patients.
67. Lipsey JR, Pearlson GD, Robinson RG, Rao K, Price TR: Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984, 1:297-300.
68. Roffler-Tarlov S, Schildkraut JJ, Draskoczy PR: Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monamines in the rat brain. Biochem Pharmacol 1973, 22:2923-2926.
69. Albert ML, Bachman DL, Morgan A, Helm-Estabrooks N: Pharmacotherapy for aphasia. Neurology 1988, 36:877-879.
70. Bachman DL, Morgan A: The role of pharmacotherapy in the treatment of aphasia. Aphasiology 1988, 3-4:225-228.
71. Sabe L, Leiguarda R, Starkstein SE: An open-label trial of bromocriptine in nonfluent aphasia. Neurology 1992, 42:1637-1638.
72. Gupta SR, Micoch AG, Scolaro C, Moritz T: Bromocriptine treatment of nonfluent aphasia. Neurology 1995, 45:2170-2173.
73. Sabe L, Salvarezza F, Cuerva AG, Leiguarda R, Starkstein S: A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology 1995, 45:2272-2274.
74. Walker-Batson D, Unwin H, Curtis S, Allen E, Wood M, Smith P, Devous MD, Reynolds S, Greenlee RG: Use of amphetamine in the treatment of aphasia. Restor Neurol Neurosci 1992, 4:47-50.
75. Goldstein LB, Davis JN: Physician prescribing patterns after ischemic stroke. Neurology 1988, 38:1806-1809. The authors carried out a survey indicating that several of the drugs that laboratory studies suggest may be harmful are commonly given to patients after stroke to treat coincident medical problems. Benzodiazepines are among the most frequently used of these potentially harmful drugs and are prescribed primarily as sleep aides.
76. Porch BE, Feeney DM: Effects of antihypertensive drugs on recovery from aphasia. Clin Aphasiology 1986, 16:309-314.
77. Goldstein LB, Matchar DB, Morgenlander JC, Davis JN: The influence of drugs on the recovery of sensorimotor function after stroke. J Neuro Rehab 1990, 4:137-144.
78. Goldstein LB, Sygen in Acute Stroke Study Investigators: Common drugs may influence motor recovery after stroke. Neurology 1995, 45:665-871. A second, retrospective cohort study which found a detrimental effect of hypothesized detrimental drugs (clonidine, prazosin, phenytoin, phenobarbital, benzodiazepines, dopamine receptor antagonists) on recovery of both motor impairment and disability.
79. The SASS Investigators: Ganglioside GM1 in acute ischemic stroke: the SASS trial. Stroke 1994, 25:1141-1148.